Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis

PURPOSE: Portal vein tumor thrombosis (PVTT) from cancer involving the liver carries a dismal prognosis, with median overall survival (OS) ranging from 2 to 5 months. While treatment with yttrium-90 ((90)Y) radioembolization alone may improve outcomes, overall prognosis remains poor. We hypothesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jason, Ladbury, Colton, Amini, Arya, Glaser, Scott, Kessler, Jonathan, Lee, Aram, Chen, Yi-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497860/
https://www.ncbi.nlm.nih.gov/pubmed/34619828
http://dx.doi.org/10.3857/roj.2021.00213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497860/
https://www.ncbi.nlm.nih.gov/pubmed/34619828
http://dx.doi.org/10.3857/roj.2021.00213

Ejemplares similares